Is anaerobic coverage necessary for aspiration pneumonia with metronidazole or Augmentin?
NEJM JWatch reports from a large retro study with N ~ 4000

Findings show no added mortality benefit but an increased risk of CDI

journal.chestnet.org/article/S0012-…

#IDTwitter #IDXposts

Interesting… U.S. FDA authorizes Prenosis software as first #AI tool that can diagnose sepsis!
“…Sepsis ImmunoScore, uses 22 different parameters like temperature, heart rate and cell counts to help clinicians assess a patient's risk of sepsis…” buff.ly/49CXreh

.Infectious Disease Connect is hiring! We are looking for an ID pharmacist to fill our Director of Customer Experience and Infectious Disease Clinical Pharmacist position. Feel free to reach out with any questions (DMs open).

Posting: idctelemed.com/about/careers/
SIDP Erin McCreary

Infectious Disease Connect is  #hiring ! We're seeking a Director of Customer Experience and Infectious Disease Clinical Pharmacist to join our team.

Learn more and apply: app.trinethire.com/companies/3483…

.Infectious Disease Connect is hiring! We are looking for an ID pharmacist to fill our Director of Customer Experience and Infectious Disease Clinical Pharmacist position. Feel free to reach out with any questions (DMs open).

Posting: idctelemed.com/about/careers/
SIDP Erin McCreary

This made my day, thanks Nick Johnson!

I hope this starts a broader discussion of how we can move towards a 'one ID' mentality within the profession.

Drastic measure are needed across the board for the specialty. We believe this can be one of the solutions!

A 🆕️🌟Meta-Analysis & Meta-Regression of RCTs Clinical Infectious Diseases
Adjunctive systemic corticosteroid therapy in patients hospitalized with CAP was associated with a reduction in all-cause mortality by day 30
The benefits more pronounced in sCAP #IDXposts #MedEd
academic.oup.com/cid/article-ab…

It’s that time of year again! 📣 If you are interested in pursuing an ID PGY2, join us for one of our open houses to learn about our two ID residency positions at Novant Health in Charlotte and Winston-Salem, NC. Come join our team, we’re fun 🤓 #IDtwitter #PharmRes #TwitteRx

The 'pro' piece on the SAAR is now out in ASHE Journal:

cambridge.org/core/journals/…

Awesome work, Yi Guo and Libby Dodds Ashley!

'Con' piece from Dan Morgan and I linked below.

Common ground piece from CDC still forthcoming.

#IDTwitter

.SIDP members, save these references for antibiograms from National Jewish’s NTM lab for your next case!!

👉🏻 doi.org/10.1093/jac/dk… (slow-growers)
👉🏻 doi.org/10.1016/j.diag… (rapid growers)

Caveat: Rapid-grower macrolide data doesn’t account for inducible resistance

Please share the knowledge 🙂:

academic.oup.com/jac/advance-ar…

Matt Davis George Thompson Scott Crabtree Alan Koff Monica Donnelley Niki Clayton, Abx Sommelier

The ID Connect team enjoyed catching up with peers, learning, and sharing during IDWeek. We are already looking forward to IDWeek 2024!

#IDWeek #IDWeek 2023

A nice and nuanced checklist to consider when thinking about PO step down for SAB

.Jeannette Bouchard When the Karius comes back with just a smidge of Rothia mucilaginosa

🔥 JUST PUBLISHED 🔥
IDSA SCCM Guideline for the evaluation of new-onset fever in adult ICU patients without severe immunocompromise
12 recommendations[all weak based]
9 best practice statements
#IDXposts #IDWeek2023
H/t 小谷 祐樹| Yuki KOTANI
Thanks Ignacio uman journals.lww.com/ccmjournal/ful…

Kim Blumenthal has observed that moxifloxacin is the fluoroquinolone allergy that patients report most often. Wes Kufel reviews the literature on cross-reaction with other FQs is about 2% and levofloxacin is generally the best tolerated #IDWeek2023 Kimberly Blumenthal, MD, MSc weskufel

FREE ACCESS THRU OCT 31-Summary of PK principles & PD targets of commonly used triazole antifungals & rationale for utility of TDM within ea agent buff.ly/3NUrNjy SIDP @erinmccreary @mattdavis138 Robbie Christian @RussLewis_BO David Andes @idpharmacist MSGERC